On the Amount of Blood Taken Up by a Female Mosquito of Culex Pipiens Pallens Coquillett

It became necessary for us to know how much microfilaria of Wuchereria bancrofti should be taken theoretically by a female mosquito in a blood meal, when supposed the microfilaria being distributed homologously in the blood of a patient and the number o

Soil respiration in a high arctic glacier foreland in Ny-Alesund, Svalbard

Soil respiration rates were measured in a successional glacier foreland in Ny-_lesund, Svalbard, and the amount of CO2 efflux during the plant-growing season was estimated using a simple regression model. Three study sites (Site 1, Site 2 and Site 3) were set up along with the primary succession in the deglaciated area of East Br_gger glacier in Ny-_lesund, Svalbard, Norway (79‹N 12‹E). Another study site, Site RB, was set up on a riverbed in the Bay River between Site 2 and Site 3. Soil respiration (SR), air temperature at 10 cm height (AT), soil surface temperature (SST) and soil temperature at 1 cm depth (ST) were measured at the four study sites with an open-airflow system using an infra-red gas analyzer from July to August, 1995. The mean soil respiration rate varied among the four sites: 6.2, 44, 63 and 3.7 mg CO2 m-2 h-1 at Site 1, Site 2, Site 3 and Site RB, respectively. These differences in the soil respiration rate among the four sites corresponded with the soil organic amount, microbial biomass, and root biomass. The soil respiration rate showed the best correlation with AT at Site 1, Site 2 and Site RB, and with ST at Site 3. The cumulative amount of CO2 efflux calculated using correlation equations obtained from the above relationships between SR and AT or ST was 5.8, 46, 69 and 3.3 g CO2 m-2 at Site 1, Site 2, Site 3 and Site RB, respectively, for two months (from July to August, 1995). These values were extremely low compared to those of warmer ecosystems, such as low-arctic tundra, temperate mixed forests, and tropical moist forests

Microbial biomass in relation to primary succession on arctic deglaciated moraines

Microbial biomass in arctic soil was examined in relation to a primary succession on arctic deglaciated moraines in Ny-Alesund, Svalbard (79°N, 12°E). Soil samples at four study sites representing different successional stages were collected at every 1cm depth from the soil surface to 3cm depth in early August 1995. Microbial biomass was measured with a substrate-induced respiration procedure. The microbial biomass was highest at the soil surface (0-1cm depth) in all successional stages, and decreased to a negligible amount at 3cm depth. Mean microbial biomass in 0-2cm layer increased from 0.06mgCg^ soil d. w. in the youngest site to 1.03mgC g^ soil d. w. in the oldest site, which is comparable to ecosystems in warmer regions. Throughout all successional stages, there was positive high correlation between soil carbon or nitrogen content and microbial biomass

ジャミング転移現象を用いた医療装置の体表固定に関する研究

学位の種別: 課程博士審査委員会委員 : （主査）東京大学准教授 中島 義和, 東京大学教授 田畑 仁, 東京大学教授 上坂 充, 東京大学教授 鄭 雄一, 東京大学教授 杉田 直彦, 東京大学准教授 古川 克子University of Tokyo(東京大学

Molecular-targeted Therapy for Metastatic Renal Cell Carcinoma As First-line Therapy: A Single Institution 13-year Experience

We aimed to identify the role of first-line monotherapy with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKI) in patients with metastatic RCC. Eligible patients were categorized into three groups (favorable, intermediate, and poor risk) according to the International Metastatic RCC Database Consortium risk criteria. Overall survival (OS) was the primary endpoint. Survival was compared using the log-rank test. A total of 108 patients were retrospectively analyzed. The numbers of patients in the favorable-, intermediate-, and poor-risk groups were 32 (30%), 66 (61%), and 10 (9%), repestively. The median OS values in the entire cohort was 36 months (95% confidence interval [CI] 29-53). The median OS in the favorable, intermediate, and poor risk groups were 94 months (95% CI: 43-Not reached), 30 months (95% CI: 20-38), and 8 months (95% CI: 0-Not reached), respectively (p<0.05). Prior nephrectomy, clear cell histology, clinical T stage ≤2, no metastasis at the time of diagnosis, nivolumab beyond first-line therapy, and objective response to VEGFR-TKIs were factors significantly prolonging OS on univariate analysis. VEGFR-TKI monotherapy as first-line therapy was an effective treatment option for patients with metastatic clear cell RCC with favorable risk